Osborne Clarke LLP acts for a varied client roster, notably including BioNTech, Turbine, and Advent Life Sciences. Practice co-head Will James is a patent litigator who regularly acts for biotech, electronics, and medical device companies in disputes; while co-head Matthew Edwards maintains a corporate-focused practice, and advises companies and investors on M&A and venture capital investments. Marcus Vass primarily advises digital health companies on outsourcings and privacy matters. Peter Rudd-Clarke has broad experience in defending product liability claims and handling regulatory compliance issues. Having joined the team from Marks & Clerk in October 2022, Trevor Crosse has deep knowledge of SPC disputes and exclusivity rights.
Key clients
- Santen
- BioNTech
- Turbine
- Basecamp Research
- King's College London
- UCL Technology Fund
- Optellum
- AviadoBio
- Advent Life Sciences
- Ada Digital Health
- Doctor Care Anywhere
- Elephant Health
- Koa Health
- Thriva
- Science Creates Ventures
Work highlights
- Advised BioNTech on its acquisition of InstaDeep Ltd for up to £562m.
- Advising Amgen on its litigation strategy in respect of the competitive new clinical field of cholesterol-lowering antibodies for the treatment of cardiovascular disease.
- Advised AviadoBio Ltd on its $80m Series A financing round.
Lawyers
Practice head
The lawyer(s) leading their teams.
Will James, Matthew Edwards, Marcus Vass, Richard Wilkinson